• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Danaher names new chief technology and AI officer, EVP for Life Sciences

Danaher names new chief technology and AI officer, EVP for Life Sciences

June 27, 2025 By Sean Whooley

Danaher Logo 2025

Danaher (NYSE: DHR) announced today that it appointed a new chief technology and AI officer and a new EVP to lead Life Sciences.

The company chose Martin Stumpe to take on the role of chief technology and AI officer, effective Oct. 1, 2025. It selected Greg Milosevich to become EVP with responsibility for Life Sciences, effective July 1, 2025.

Stumpe, who joined Danaher last year as chief data and AI officer, reports directly to President and CEO Rainer Blair in his new post. The company said the appointment “marks a pivotal step in its digital transformation as it looks to accelerate the integration of AI into its businesses.

Prior to joining Danaher, Stumpe spearheaded AI initiatives for precision medicine at Tempus. Before Tempus, he founded the Cancer Pathology project at Google and served on the Kepler team at NASA’s Ames Research Center.

“Danaher is committed to building a future where science, data and technology work seamlessly to improve human health,” said Rainer Blair. “Martin is a visionary technology leader with a deep understanding of how AI and data can transform healthcare. His track record of innovation, combined with his passion for applying advanced technologies to improve human health, makes him the ideal leader to further accelerate our digital transformation.”

More about new Danaher Life Sciences EVP Greg Milosevich

Milosevich became Danaher’s VP and group executive of the Life Sciences Innovations Group in 2021. His expanded role makes him an executive officer of Danaher, also reporting to Blair.

He originally joined the company in 2010 through its acquisition of Molecular Devices. Since then, he took on roles of increasing responsibility across multiple businesses.

In his most recent role, Milosevich oversaw multiple Danaher companies, including Beckman Coulter Life Sciences, Sciex, Leica Microsystems, Molecular Devices, Phenomenex, Abcam, IDBS and Genedata.

“Greg has played a pivotal role in advancing our Life Sciences Innovations Group over the past four years,” said Blair. “His consistent ability to deliver results, deep customer focus and talent for building high-performing teams—combined with his strong embodiment of the Danaher Business System—make him an outstanding leader. I’m confident he will continue to drive success as he takes on this expanded role.”

Filed Under: Artificial Intelligence (AI), Business/Financial News, Machine Learning (ML) Tagged With: danaher, Danaher Corp., Personnel Moves

More recent news

  • Carlsmed names chief product and AI officer as it claims CMS reimbursements
  • Integra LifeSciences says Cincinnati plant flooding will cost millions
  • Mendaera rolls out handheld needle robot paired with Butterfly ultrasound probe
  • Edwards earns FDA approval for first-of-its-kind size-adjustable pediatric heart valve
  • Leading medical device experts and MDO launch Medtech Innovation Board

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy